Moderna’s stock tumbles after a disappointing outlook for revenue and the need to accelerate its cost-cutting plan.

"The S&P 500 is a different animal than in prior cycles," Bank of America's Savita Subramanian said in a note Friday.

The first few earnings reports from S&P 500 firms have already started to trickle in. But the fourth-quarter earnings ...

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...

On January 3, the Indian stock market fell significantly. Meanwhile, in China, the COVID-like HMPV virus is wreaking havoc, ...

Following a period of growing consumer confidence and increased discretionary spending amid lower inflation post-COVID, retailers have an opportunity to build 2025 may be a transformative year for ...